Results 101 to 110 of about 186,128 (186)

Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion. [PDF]

Int Ophthalmol, 2023
Gildea D, Tang B, Baily C, Ryan A.
europepmc   +1 more source

Draft a protocol for an observational study for anti-VEGF therapy in age related macular degeneration [PDF]

, 2015
Μακρή, Όλγα
core   +1 more source

Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study

Eye and Vision
Background A post hoc analysis of the STAR study, which was a 48-week, phase IV, multicenter randomized controlled multicenter clinical trial was performed. This study aims to identify the baseline factors associated with visual and anatomic changes over
Tsung-I. Wang, Jinfeng Qu, Ran Tang, Xuan Shi, Xin Ying, Ye Tao, Xiaoxin Li   +6 more
doaj   +1 more source

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients

Clinical Ophthalmology, 2018
Keiko Azuma,1 Ryo Asaoka,1 Aya Matsuda,2 Jihee Lee,3 Kimiko Shimizu,1 Hiroko Inui,1 Hiroshi Murata,1 Asako Ogawa,1 Motoshi Yamamoto,1 Tatsuya Inoue,1 Ryo Obata1 1Department of Ophthalmology, Graduate School of Medicine and Faculty of Medicine, The ...
Azuma K, Asaoka R, Matsuda A, Lee J, Shimizu K, Inui H, Murata H, Ogawa A, Yamamoto Motoshi, Inoue T, Obata R   +10 more
doaj  

Efficacy of a Modified Treat-and-Extend Aflibercept Regimen for Macular Oedema in Eyes with Central Retinal Vein Occlusion: 2-Year Prospective Study. [PDF]

J Clin Med, 2023
Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Kawashima H, Yanagi Y.   +6 more
europepmc   +1 more source

Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis. [PDF]

Eye (Lond), 2023
Nichani PAH, Popovic MM, Dhoot AS, Pathak A, Muni RH, Kertes PJ.   +5 more
europepmc   +1 more source

The need for a pragmatic, individualized treat-and-extend (T&E) treatment paradigm for centre-involving diabetic macular oedema. [PDF]

Eye (Lond), 2023
Chaudhary V, Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group.   +1 more
europepmc   +1 more source

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing. [PDF]

J Clin Med
Wu KY, Qian SY, Camiré A, Kim DT, Giunta M.   +4 more
europepmc   +1 more source

Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen. [PDF]

BMC Ophthalmol
Plasencia C, Eschle J, Hatz K.
europepmc   +1 more source

Predictors of treatment outcomes following treat-and-extend regimen with aflibercept for branch retinal vein occlusion: post-hoc analysis of the PLATON trial. [PDF]

Sci Rep, 2023
Son W, Jeong WJ, Park JM, Kim JY, Ji YS, Sagong M.   +5 more
europepmc   +1 more source